BENZENO SHARON

CIK 00017808541 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001780854

Recent Transactions

50 trades

Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-12-04$8.46/sh+4,157→ 305,238 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-12-04$16.85/sh−12,604→ 296,791 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-12-04$12.14/sh+4,290→ 301,081 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-12-04−4,157→ 62,360 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-12-04−4,290→ 12,871 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-21$6.55/sh+49,480→ 367,939 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-11-21−49,480→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-21$3.99/sh+83,145→ 605,268 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-21$6.27/sh+834→ 297,625 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-11-21−34,375→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-11-21−83,145→ 116,404 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-11-21−119,809→ 17,161 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-11-21−834→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-21$7.27/sh+34,375→ 402,314 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-21$12.14/sh+119,809→ 522,123 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-11-21−20,834→ 0 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-21$16.91/sh−308,477→ 296,791 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-21$6.55/sh+20,834→ 318,459 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-20$12.14/sh+68,961→ 594,716 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-20$16.54/sh−297,925→ 296,791 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-11-20−68,961→ 136,970 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-11-20$8.46/sh+133,032→ 525,755 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-11-20−133,032→ 66,517 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-05$6.99/sh−3,065→ 392,723 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-05$6.98/sh−41,600→ 395,788 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-03-04+165,027→ 165,027 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-04+109,973→ 437,388 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-05$3.44/sh−18,644→ 327,415 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-05$3.43/sh−10,746→ 346,059 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-04+132,979→ 356,805 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2024-03-04+199,549→ 199,549 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2023-03-06+199,549→ 199,549 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2023-03-06$8.57/sh−11,749→ 223,826 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2023-03-06+132,979→ 235,575 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-07$12.01/sh−2,670→ 102,596 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2022-03-04+205,931→ 205,931 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-04+82,372→ 105,266 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-15$31.71/sh+1,354→ 24,248 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-03-15−1,354→ 47,396 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-15$41.85/sh−1,014→ 22,894 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-15$41.22/sh−340→ 23,908 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-04+22,894→ 22,894 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-03-04+57,234→ 57,234 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-03-01−1,563→ 34,375 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-03-01−2,604→ 20,834 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-01$57.57/sh−6,210→ 561 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-01$6.55/sh+2,604→ 5,208 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-01$6.55/sh+2,604→ 2,604 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-03-01−2,604→ 49,480 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-01$58.17/sh−561→ 0 total

Companies

Adaptive Biotechnologies Corp
Chief Commercial Ofc Imm Med
$ADPT

Recent Filings

Address

C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1165 EASTLAKE AVENUE EAST

SEATTLE, WA, 98109

View on SEC.gov